China Medical GatewayLoading your healthcare gateway…

Chen Jue

Chen Jue — Chief Physician — Coronary Heart Disease Ward 1 — Fuwai Hospital

Specialties

Interventional treatment for coronary heart disease

Education

Graduated in July 1985 from the Medical Department of Hunan Medical University, majoring in Medicine

Professional Experience

Female, Chief Physician at the Coronary Heart Disease Diagnosis and Treatment Center, Professor, currently Deputy Director of Ward 4 at Fuwai Hospital Cardiovascular Department. Born in November 1963, graduated in July 1985 from the Medical Department of Hunan Medical University with a degree in Clinical Medicine. After graduation, she joined the Cardiology Department of Beijing Fuwai Cardiovascular Hospital. From resident physician, attending physician, deputy chief physician to chief physician, she has been working on the front line of clinical practice for more than 20 years, accumulating extensive clinical experience in the diagnosis and treatment of cardiovascular diseases, and is especially skilled in the diagnosis and drug treatment of coronary heart disease angina and acute coronary syndromes. She has participated in multiple large international multicenter drug clinical trials, gaining extensive knowledge and experience in drug clinical research. Since 1994, she has been engaged in interventional diagnosis and treatment of coronary heart disease. In 1995, she went to San Donato Hospital in Milan, Italy, for further study in coronary angiography and interventional treatment. Through nearly 18 years of dedicated study and work, she has become proficient in the characteristics and operating techniques of various complex lesions, accumulating rich experience in angiography of abnormal-origin coronary arteries and post-bypass graft vessels and their interventional treatment. To date, she has performed over 10,000 coronary angiographies and more than 6,000 coronary stent implantation surgeries, including various left main trunk lesions, bifurcation lesions, and chronic total occlusions, strictly adhering to indications for interventional therapy, with high surgical success rates and low complication rates. She has published dozens of papers in national core journals, served as associate editor for three books, and contributed to several others. She is currently mainly engaged in clinical and interventional work related to coronary heart disease. Major international multicenter drug clinical studies she has participated in include: 1. Safety and tolerability evaluation of Tirofiban combined with aspirin and clopidogrel during coronary stent implantation; 2. Safety and efficacy evaluation of Tirofiban combined with low-molecular-weight heparin or regular heparin for the treatment of unstable angina and non-Q-wave myocardial infarction; 3. AtoZ study; 4. TIMACS study; 5. CURRENT study.

Return to Home